[Diftalone in the prevention and therapy of inflammatory complications of dental surgery].
The capacity of diphthalone to prevent  postoperative inflammation was evaluated in 46 patients who had undergone dental surgery. The drug was always administered at a dose of 1000 mg/die for 5-7 days using two different therapeutic schedules, the before and after the operation in 23 patients and only afterwards in the other half. Results were satisfactory although the most evident benefits were obtained with the first schedule, namely when treatment was commenced two days prior to operation. Tolerance was good.
D000293:Adolescent; D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy / Q000517:prevention & control; D011724:Pyridazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013515:Surgery, Oral; D013997:Time Factors
D011724:Pyridazines
Ul diftalone nella prevenzione e nella terapia delle complicazioni flogistiche della chirurgia dentaria